Royalty Pharma plc (RPRX) Competitors & Peers
The 5 largest companies in the same industry as Royalty Pharma plc, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Supplier | $547.89 | P/E 35.3RSI 58Cap 139.1 B |
| REGN | Peer | $916.06 | P/E 20.2RSI 65Cap 94.9 B |
| ARGX | Peer | $971.55 | P/E 33.6RSI 63Cap 61.1 B |
| RVMD | Peer | $193.06 | RSI 50Cap 41.0 B |
| CSLLY | Peer | $34.45 | P/E 18.2RSI 71Cap 66.6 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- VRTXSupplier
Royalty Pharma owns cystic fibrosis franchise (Trikafta) royalty from Vertex.
Model-inferred, unverified — treat as a lead, not evidence